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Abstract
SUMOylation is a post-translational modiﬁcation that affects a large number of proteins, many of which
are nuclear. While the role of SUMOylation is beginning to be elucidated, it is clear that understanding
the mechanisms that regulate the process is likely to be important. Control of the levels of SUMOylation
is brought about through a balance of conjugating and deconjugating activities, i.e. of SUMO (small
ubiquitin-related modiﬁer) conjugators and ligases versus SUMO proteases. Although conjugation of SUMO
to proteins can occur in the absence of a SUMO ligase, it is apparent that SUMO ligases facilitate the
SUMOylation of speciﬁc subsets of proteins. Two SUMO ligases in Schizosaccharomyces pombe, Pli1 and
Nse2, have been identiﬁed, both of which have roles in genome stability. We report here on a comparison
between the properties of the two proteins and discuss potential roles for the proteins.
Introduction
The mechanisms involved in the post-translational modi-
fication of proteins by SUMOylation resemble those
associated with ubiquitination. However, there are a number
of significant differences in the two processes. SUMO (small
ubiquitin-related modifier), like ubiquitin, is produced as
a precursor protein that is processed to the mature form
to reveal a double glycine (-GG) motif. It is then activated
by a SUMO activator (which is heterodimeric, unlike the
ubiquitin activator that consists of a single protein), and then
passed to a SUMO conjugator (E2), of which there is only
one, unlike the case with ubiquitination, where there are
several E2s. However, perhaps the most striking difference
is in the requirement for a SUMO ligase. While there are
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dozens, or perhaps even hundreds, of ubiquitin ligases, far
fewer SUMO ligases have so far been characterized.
SUMO ligases fall into a number of classes. The first is the
PIAS [protein inhibitor of activated STAT (signal transducer
and activator of transcription)] family: members of this class
contain an SP-RING[Siz-PIASRING(really interestingnew
gene)] related to RING zinc finger domains (Figure 1A). As
well as the mammalian PIAS proteins (e.g. [1–3]), this group
includes the Saccharomyces cerevisiae Siz1, Siz2, Mms21
and Zip3 proteins [4–6], the Schizosaccharomyces pombe
Pli1 and Nse2 proteins [7,8] and human Mms21 [9]. Other
SUMO ligases include RanBP2 (Ran-binding protein 2)
[10], Pc2 (polycomb 2) protein [11] and HDAC2 [11a].
The PIAS family of SUMO ligases
The presence of a RING zinc finger domain in the PIAS
family of SUMO ligases is reminiscent of the largest family
of ubiquitin E3 ligases. However, whether this domain folds
similarly to that in the ubiquitin E3s is unknown, since
the RING domains in the SUMO ligases lack two of the
conserved cysteine residues that are present in the ubiquitin
E3s. Immediately upstream of the SP-RING motif, the Siz
and PIAS proteins, but not the Nse2/Mms21 SUMO ligases
contain a SAP (Scaffold attachment factor, Acinus and PIAS)
domain at the N-terminus. SAP regions in these and other
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Figure 1 Comparison of the phenotypes of pli1-d and nse2-SA mutants
(A) Comparison of the organization of the Pli1 and Nse2 proteins. (B) Comparison of the sensitivities of nse2-SA and pli1-d
to DNA-damaging agents, the DNA synthesis inhibitor, HU, and the microtubule inhibitor, TBZ. Aliquots (7 µl) of 10-fold
serial dilutions were spotted on to plates as indicated. (C) ChIP using anti-SUMO sera. ChiP was undertaken on asynchronous
cultures according to the method of Strahl-Bolsinger et al. [30] using anti-SUMO serum [31]. QPCR (quantitative PCR) was
undertaken using QuantiTect SYBR Green PCR master mix (Qiagen). Fold enrichments were calculated as described in [32].
(D) Silencing assays. Aliquots (7 µl) of 10-fold dilutions of wild-type, nse2-SA and pli1-d cells containing the ura4 gene
inserted at cnt1, imr1R, otr1R [33,34] or at the rDNA [35] were plated on to media as indicated.
proteins are capable of binding DNA (e.g. [12]). Although
the Nse2/Mms21 proteins do not contain a SAP domain,
they are associated with DNA, being components of the
chromatin-associated Smc5/6 complex [13,14].
Evidence of a role for SUMO and SUMO
ligases in genome stability
Evidence of a role for SUMO in genome stability came from
early studies on mutants defective in SUMO conjugation
that displayed nuclear abnormalities as well as sensitivities
to a range of DNA-damaging agents, such as UV, IR, methyl
methanesulfonate and the DNA synthesis inhibitor, HU
(hydroxyurea) [15–18].
Following the first identification of the Siz1 and Siz2
SUMO ligases in S. cerevisiae [4], two related SUMO ligases,
Pli1 andNse2, were identified in S. pombe [7,8]. Surprisingly,
unlike mutations in previously identified components of the
SUMOylation pathway, deletion of pli1 results in a rather
subtle phenotype, despite the fact that the level of SUMOyla-
tion in these cells is dramatically reduced [7]. In this respect, it
C©The Authors Journal compilation C©2007 Biochemical Society
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resembles the S. cerevisiae siz1 and siz2 genes [4]. In contrast,
Nse2 is essential for cell viability [8]. However, the essential
function ofNse2 is likely to be due to the fact that the protein
is a component of the essential Smc5/6 complex rather than to
its SUMO ligase function, since mutation of the RING zinc
finger-like domain to produce the nse2-SA strain, causing loss
of SUMO ligase activity, results in viable cells [8]. Unlike the
situation with pli1-d, the level of high-Mr SUMO-containing
species in nse2-SA cells resembles that in wild-type cells.
Comparison of the phenotypes of pli1-d and nse2-SA cells
indicates that the mutants respond quite differently to DNA-
damaging agents (Figure 1B). nse2-SA cells are sensitive to
HU, methyl methanesulfonate and IR, while pli1-d cells are
not, but instead are sensitive to the microtubule inhibitor,
TBZ (thiabendazole). These results imply that the two
SUMO ligases have at least some non-overlapping functions
in maintaining genome stability.
Comparison of the properties of S. pombe
SUMO ligase mutants
ChIP (chromatin immunoprecipitation) using anti-SUMO
serum indicates that, in S. pombe, SUMO is enriched at
regions of complex chromatin structure (Figure 1C). This
enrichment is dependent on a functional Hus5 (SUMO
conjugator), indicating that the SUMO present at these loci
is likely to be in the form of SUMO conjugates, rather than
free SUMO. These results are consistent with the recent ob-
servation that Hus5 is enriched at regions of heterochromatin
[19]. In particular, there is substantial enrichment of SUMOat
telomeres and at the central regions of S. pombe centromeres.
These results imply that SUMOylation has role(s) at these
regions. In contrast with what we observe with SUMO,
ChIP of Pli1 and Smc6 (as a marker for Nse2) indicates
that, while Pli1 and Smc6 are associated with the chromatin,
neither of the proteins is specifically enriched at telomeres or
centromeres in asynchronously dividing cultureswith a slight
enrichment of Smc6 at telomeres (F.Z. Watts and A. Irmisch,
unpublished work).
If SUMO ligases have roles at telomeres and centromeres,
it might be expected that pli1-d or nse2-SA mutants would
display mini-chromosome instability. This is indeed the
case: pli1-d and nse2-SA cells show an increase in mini-
chromosome loss of 10- and 15-fold respectively over that ob-
served in wild-type cells [7] (F.Z. Watts, unpublished work).
The loss of mini-chromosome stability in the SUMO
ligase mutants could arise through defects in a number of
different processes.One possibilitymight be due to problems
associated with telomere maintenance. Early experiments
demonstrated that the S. pombe SUMO-null mutant has
elongated telomeres compared with those in wild-type cells
[17]. Longer telomeres have also been detected in pli1-d cells,
but not in nse2-SA [20]. These results add to the notion that
Pli1 and Nse2 contribute differently to genome stability.
Other regions important for chromosome segregation
are the centromeres. Unlike the centromeres in S. cerevisiae
that are of the order of 100 bp in length, those in S. pombe
more closely resemble the centromeres in higher eukaryotes
and are approx. 40–50 kb in length. Owing to their complex
chromatin structure, genes inserted into these regions are
subjected to transcriptional silencing (e.g. [21]). To assay for
silencing in S. pombe the ura4 gene is frequently used since
both expression and lack of expression can be tested, using
–ura and 5-FOA (5-fluoro-orotic acid)-containing media
respectively (5-FOA kills cells that are ura+). In pli1-d cells,
this silencing ability is lost at imr1R, the right-hand side
inner repeat region of the centromere on chromosome I, as
observed by the growth on –uramedium and the absolute loss
of growth on 5-FOA plates [7] (Figure 1D). Interestingly,
loss of silencing is not observed at any of the centromeric
loci in the nse2-SA mutant (Figure 1D). In addition to the
silencing defect at imr1R, pli1-d cells undergo increased gene
conversion at this locus [7]. Loss of silencing in pli1-d cells is
also observed at the rDNA locus (which consists of hundreds
of tandemly repeated 10.9 kb copies of the 17, 5.8 and 25 S
sequences) on chromosome III (Figure 1D).
The role of SUMO and SUMO ligases in
meiosis
In addition to their roles in genome stability during the
mitotic cell cycle and in response to DNA damage, SUMO
and SUMO ligases also have role(s) in meiosis [6,22,23].
Early studies in Drosophila on a SUMO conjugator mutant
implicated SUMO as being required for dissociation of
heterochromatic regions of homologues at the end of meiotic
prophase I [22]. More recently, it has been demonstrated
that SUMO is associated with pachytene chromosomes in S.
cerevisiae [6,23] and that mutants in the SUMO conjugator,
Ubc9, are defective in synapsis. We have analysed meiosis
(more specifically, the ability to form spores) in nse2-
SA/nse2-SA and pli1-d/pli1-d homozygotes and compared it
with meiosis in wild-type and hus5-62/hus5-62 (the hus5-62
mutation allows interaction of Hus5 with SUMO, but
not the conjugation of SUMO on to target proteins [23a])
homozygotes. Figure 2(A) indicates that unlike the case with
wild-type cellswhere regular four-spore asci are observed, the
hus5-62 diploids form aberrant asci. This is also the case with
pli1-d diploids, but not with nse2-SA diploids. Spore viability
is dramatically reduced in hus5-62 and pli1-d diploids (23 and
32% respectively) compared with that observed in wild-type
and nse2-SA diploids (95 and 92% respectively).
One of the processes associated with meiosis is recombin-
ation. We were therefore interested in determining whether
Pli1 is required for genetic crossing over during meiosis. One
of the intervals that we investigated was between ade7 and
arg6 (approx. 72 kb apart) on chromosome II (Figure 2B).
The frequency of crossing over in pli1-d cellswas reduced 1.9-
fold compared with that in the wild-type cross; this compares
with a reduction of cross-over frequency for rhp51 (defective
in the S. pombe homologue of Rad51) of 2.3-fold [24].
Targets
While many proteins can be SUMOylated without the aid of
a ligase in vitro if the SUMO conjugator is present in excess,
it is likely that SUMO ligases facilitate the SUMOylation
C©The Authors Journal compilation C©2007 Biochemical Society
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Figure 2 pli1-d but not nse2-SA is defective in meiosis
(A) Strains were crossed for 3 days on sporulation medium and then photographed using a Zeiss AxioPlan 2 microscope.
(B) Frequency of crossing over between the arg6-1 and ade7-152 mutations on chromosome II. Spores were plated on to
rich medium and then replica plated separately on to plates lacking arginine or adenine.
Figure 3 Nse2 and Pli1 act as SUMO ligases on different targets
In vitro SUMOylation assays were undertaken on 35S-labelled proteins as indicated using the methods of Ho et al. [31] and
Andrews et al. [8]. (A) Rad22; and (B) Smc6; molecular names are in kDa. (C) Summary of dependency of SUMOylation of
selected targets on Pli1 and Nse2. (D) Scheme showing the involvement of SUMOylated proteins in DNA-damage-response
pathways.
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of specific subsets of proteins in vivo. To date, Pli1 has
been shown to act as a SUMO ligase for the recombination
protein Rad22 (the homologue of Rad52) [7] (Figure 3A). In
contrast, Nse2 does not affect the SUMOylation of Rad22,
but facilitates the SUMOylation of some of the members
of the Smc5/6 complex, namely Smc6, Nse3 and itself [8]
(Figure 3B). In addition to these substrates, we have tested a
number of other proteins in in vitro SUMOylation assays to
determine whether they are dependent on either Pli1 or Nse2
for SUMOylation (Figure 3C). From these results, it is clear
that some proteins require either Pli1 or Nse2 for SUMOyla-
tion, while SUMOylation of other proteins can be facilitated
by both Pli1 and Nse2 or are not affected by incubation with
either of the two ligases. For example, SUMOylation of two
topoisomerases, Top1 and Top3, and the non-homologous
end-joining protein, Ku70, is facilitated by Pli1, but not by
Nse2 (Figure 3C). Unlike Rad22, where SUMOylation is
enhanced by Pli1, SUMOylation of another recombination
protein Rad32 (the homologue of Mre11) is not enhanced by
either Pli1 or Nse2. In contrast, SUMOylation of the RecQ-
like helicase Rqh1 can be facilitated by both Pli1 and Nse2.
Of these proteins tested in vitro, the dependency on a specific
ligase in vivo has been demonstrated for Smc6 and Rad22
[7,8]. It will now be necessary to analyse SUMOylation of
the remaining proteins in vivo to confirm these results.
Substrate specificity has also been observed for SUMO
ligases in other organisms (e.g. [25]). However, it appears that
the requirement for specific ligases for SUMOylation of indi-
vidual proteins may differ between different organisms. For
example, SUMOylation of Ku70 is facilitated byMms21 (the
homologue of Nse2) in S. cerevisiae, but by Pli1 in S. pombe.
Summary
When compared with the number of ubiquitin ligases,
relatively few SUMO ligases have been characterized to date.
Since genomes contain large numbers of genes encoding
RING zinc finger proteins, it is quite possible that more
SUMO ligases will be identified.
Figure 3(D) shows that SUMOylation is likely to
contribute to genome stability through the modification of
proteins in many of the DNA-damage-response pathways.
While a number of these proteins have been shown to be
modified in other organisms, it appears that SUMOyl-
ation, and the regulation of SUMOylation, of individual
proteins may differ between organisms. For example, PCNA
(proliferating-cell nuclear antigen) is clearly SUMOylated
during S-phase in S. cerevisiae [26,27] but this is not the case
in S. pombe or mammals [28].
Comparison of the phenotypes of pli1-d and nse2-SA in-
dicates thatwhile both proteins have roles in genome stability,
they have at least some non-overlapping roles. Pli1 appears to
be required formaintaining the stability of regions of complex
chromatin structure, whereas Nse2 is likely to have a more
global role, possibly in processes required for repair or for re-
covery from replication fork collapse, e.g. as described in [29].
For Pli1, it might be expected that some of its key substrates
are associated with telomeres or centromeres. In this respect,
it is interesting to note that Rad22, a Pli1-dependent target, is
enriched at telomeres, implying that Rad22 might have a role
in the elongated telomere phenotype in pli1-d cells. However,
this does not appear to be the case, as the elongated telomeres
have been shown to be due to increased telomerase activity
[20]. Thus, while it is clear that Pli1 and Nse2 have roles in
genome stability and that each of them has specific targets,
the identities of the key substrates responsible for the various
aspects of SUMO function remain to be determined.
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